Methemoglobinemia Secondary to Clofazimine Treatment for Chronic Graft-Versus-Host Disease
1998; Elsevier BV; Volume: 92; Issue: 12 Linguagem: Inglês
10.1182/blood.v92.12.4872.424a43a_4872_4873
ISSN1528-0020
AutoresVaneuza de A. Moreira, Bruno C. Medeiros, Carmen Bonfim, Ricardo Pasqüini, Carlos Roberto de Medeiros,
Tópico(s)Erythrocyte Function and Pathophysiology
ResumoTo the Editor: Chronic graft-versus-host disease (cGVHD) is a frequent late complication of allogeneic bone marrow transplantation (allo-BMT), affecting 20% to 50% of long-term transplant survivors.[1][1]A wide combination of agents have been used as primary therapy for extensive cGVHD,[2][2] [3][3
Referência(s)